![]() ![]() ![]() Minor bleeding rates have been found to be high as 15% per year. How serious is the problem with oral anticoagulants?įrom published studies, the incidence of major bleeding in patients treated with warfarin ranges from 0.4% to 7.2% per year. More importantly, the Joint Commission has designated cautious use of an oral anticoagulant as part of the National Patient Safety Goals (NQF). In any case, proactive measures and targeted education should be encouraged to prevent adverse effects associated with the newer anticoagulants. Unlike warfarin, the newer oral anticoagulants do not have a long track record in clinical medicine and hence, it is too soon to claim that they are safer. Many reports have appeared on the risk of bleeding when the anticoagulants are used concurrently with other similar agents (antiplatelet drugs), when the drug treatment is duplicated, in the presence of dosing errors, when there is accidental discontinuation of treatment and when there are problems with monitoring. Oral anticoagulants have been classified as high alert medications according to the Institute of Safe Medication Practices (ISMP) because they have the potential for harm when used clinically. There are countless case reports indicating the use of oral anticoagulants is more likely to require hospital admission, and prolonged hospital stays from adverse events such as bleeding. One class of drugs that has been implicated in serious adverse drug reactions for many decades is oral anticoagulants, especially warfarin. ![]()
0 Comments
Leave a Reply. |